Form 8-K - Current report:
SEC Accession No. 0001193125-25-042467
Filing Date
2025-02-28
Accepted
2025-02-28 16:05:18
Documents
13
Period of Report
2025-02-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d821788d8k.htm   iXBRL 8-K 24736
  Complete submission text file 0001193125-25-042467.txt   146560

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20250227.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20250227_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20250227_pre.xml EX-101.PRE 11255
16 EXTRACTED XBRL INSTANCE DOCUMENT d821788d8k_htm.xml XML 3656
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 25689984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)